Giving sales the right insights, at the right moment, to do what they do best.
Providing marketing with visibility and control to manage campaigns that physicians will value.
Aktana equips life science companies with the decision support technology to quickly evaluate mountains of data, extracting only what’s relevant and valuable at the time of decision. With brand strategy as a starting point, Aktana analyzes market data, channel activity and HCP preference to provide life science companies with the insights, clarity and guidance to deliver the right information at the right time to physicians and their patients. In fact, nearly half of the world's top-20 pharmaceutical companies rely on Aktana to put complex data into context, coordinate channel activity and improve sales effectiveness by up to 30 percent.
In this two-part series, Veeva Systems SVP of Commercial Strategy Paul Shawah and Aktana CEO David Ehrlich discuss how to leverage machine learning and AI to optimize go-to-market strategy — both today and in the years to come. Part one below focuses on the current state of machine learning in life sciences commercial processes, including applications, success factors, and the effect on the HCP experience.